| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Jan 25 | LXRX Lexicon Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 0 | 230,000 | 0.00 | 230,000 |
| 26 Aug 24 | AGXRW Agile Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 1.52 | 5,080 | 7.72 k | 0 |
| 26 Aug 24 | AGXRW Agile Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 1.52 | 15,000 | 22.80 k | 5,080 |
| 3 Oct 23 | AGXRW Agile Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 20,000 | 0.00 | 20,080 |
